Literature DB >> 11229840

Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?

D Nathwani1, E Rubinstein, G Barlow, P Davey.   

Abstract

There is growing pressure to demonstrate the value of practice guidelines. We have reviewed the evidence that guidelines for the treatment of community-acquired pneumonia (CAP) change current practices and that the standardization of practices reduces costs and/or improves outcome. The most obvious barrier to implementation of the guidelines is lack of knowledge about their content; equally important are the attitudes and behavior of professionals, patients, and their caregivers. Guidelines may improve the outcome of CAP, provided that there is an association between variations in outcome and some specific processes of care. Conversely, when there is no such relationship, guidelines may reduce the cost of care without having an adverse effect on outcome. The cost-effectiveness of CAP guidelines in an individual hospital depends on the systems that are available to identify patients with CAP and to measure the processes of care. There is good evidence that following the recommendations of the CAP guidelines does improve the cost-effectiveness of care and, therefore, that an audit of CAP may be worth the effort.

Entities:  

Mesh:

Year:  2001        PMID: 11229840     DOI: 10.1086/319216

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  National study of antibiotic use in emergency department visits for pneumonia, 1993 through 2008.

Authors:  Mark I Neuman; Sarah A Ting; Ahou Meydani; Jonathan M Mansbach; Carlos A Camargo
Journal:  Acad Emerg Med       Date:  2012-05       Impact factor: 3.451

3.  Hospital pharmacists' awareness of a new antibiotic guideline in the UK: implications for practice.

Authors:  Eleanor M Woodford; Keith A Wilson; John F Marriott
Journal:  Pharm World Sci       Date:  2005-06

4.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

5.  Effect of guideline implementation on costs of hand hygiene.

Authors:  Patricia W Stone; Sumya Hasan; Dave Quiros; Elaine L Larson
Journal:  Nurs Econ       Date:  2007 Sep-Oct       Impact factor: 1.085

Review 6.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Curricula for teaching the content of clinical practice guidelines to family medicine and internal medicine residents in the US: a survey study.

Authors:  Elie A Akl; Reem Mustafa; Mark C Wilson; Andrew Symons; Amir Moheet; Thomas Rosenthal; Gordon H Guyatt; Holger J Schünemann
Journal:  Implement Sci       Date:  2009-09-21       Impact factor: 7.327

Review 8.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  Do guidelines influence the implementation of health programs?--Uganda's experience.

Authors:  Juliet Nabyonga Orem; Juliet Bataringaya Wavamunno; Solome K Bakeera; Bart Criel
Journal:  Implement Sci       Date:  2012-10-15       Impact factor: 7.327

10.  Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.

Authors:  Xiudi Han; Fei Zhou; Hui Li; Xiqian Xing; Liang Chen; Yimin Wang; Chunxiao Zhang; Xuedong Liu; Lijun Suo; Jinxiang Wang; Guohua Yu; Guangqiang Wang; Xuexin Yao; Hongxia Yu; Lei Wang; Meng Liu; Chunxue Xue; Bo Liu; Xiaoli Zhu; Yanli Li; Ying Xiao; Xiaojing Cui; Lijuan Li; Jay E Purdy; Bin Cao
Journal:  BMC Infect Dis       Date:  2018-04-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.